FridaySep 19, 2025 11:30 am

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Jumps as ARK Invest Buys $49.7M Stake, Trims Roku and Tempus AI 

Brera Holdings (NASDAQ: BREA), which is rebranding as Solmate and pivoting to a Solana-based digital asset treasury and crypto infrastructure, surged after Cathie Wood’s ARK Invest purchased 6,500,001 shares valued at about $49.72 million on Sept. 18 through ARKK, ARKW and ARKF funds. The move follows Brera’s $300 million oversubscribed private placement backed by Pulsar Group, RockawayX and ARK. Meanwhile, ARK sold 47,474 Roku (NASDAQ: ROKU) shares for roughly $4.67 million and trimmed 43,157 Tempus AI (TEM) shares for $3.73 million, while adding positions in Arcturus Therapeutics (NASDAQ: ARCT), ATAI Life Sciences (NASDAQ: ATAI), AeroVironment (NASDAQ: AVAV), Baidu (NASDAQ: BIDU)…

Continue Reading

FridaySep 19, 2025 11:15 am

Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Poised to Gain from Alaska Land, Road Policy Shifts

H.J. Res. 106 is designed to overturn the Central Yukon Resource Management Plan (“RMP”), a plan that has locked up 13 million acres of public land in Alaska The Ambler Access Project is a proposed 211-mile, industrial-use-only road that would connect Trilogy Metals’ Upper Kobuk Mineral Projects to the Dalton Highway These key policy moves to reverse land restrictions and advance the Ambler Road permit mark major inflection points for Trilogy Metals A wave of policy changes at the federal level has delivered two major developments that could unlock value for Trilogy Metals (NYSE American: TMQ) (TSX: TMQ). First, the…

Continue Reading

FridaySep 19, 2025 11:10 am

QualityStocksNewsBreaks – XTI Aerospace, Inc. (NASDAQ: XTIA) Supports FAA eVTOL Integration Program, Advances TriFan 600 Toward 2027 Demonstrator

XTI Aerospace (NASDAQ: XTIA) voiced support for the FAA’s new Electric Vertical Takeoff and Landing Integration Pilot Program (eIPP), a national initiative to accelerate certification, testing and airspace access for powered-lift aircraft. CEO Scott Pomeroy said the program signals U.S. commitment to vertical flight as XTI advances its TriFan 600, designed to combine helipad and short-runway operation with fixed-wing business jet performance. XTI has flown its Sparrow and Kestrel prototypes, is preparing its TriHawk prototype, and targets a full-scale TriFan 600 demonstrator for 2027. To view the full press release, visit https://ibn.fm/FE7e6 About XTI Aerospace, Inc. XTI Aerospace (XTIAerospace.com) (Nasdaq:…

Continue Reading

FridaySep 19, 2025 11:00 am

QualityStocksNewsBreaks – Ucore Rare Metals Inc.’s (TSX.V: UCU) (OTCQX: UURAF) RapidSX(TM) Targets REE Bottlenecks with Scalable Solution

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is positioned as the Trump administration is developing a comprehensive strategy to strengthen the nation’s critical minerals production and reduce Chinese market control through guaranteed minimum pricing for domestic rare earth producers. The company “stands uniquely positioned to capitalize on this initiative through its revolutionary RapidSX(TM) technology, which addresses critical bottlenecks in rare earth element separation and processing. A recent article discussing this reads, “The company’s flagship RapidSX technology represents a breakthrough in rare earth element separation, offering significant advantages over conventional processing methods. The RapidSX technology platform has been demonstrated to process…

Continue Reading

FridaySep 19, 2025 11:00 am

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Leveraging Positive Clinical Data to Shape Pivotal SGX942 Trial 

Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases with unmet medical need. The company’s SGX942 is a novel therapeutic aimed at alleviating oral mucositis, a debilitating side effect of cancer therapy with no FDA-approved treatment. “Severe oral mucositis (‘SOM’) often necessitates hospitalization, opioid pain management and feeding tube placement, lowering quality of life substantially. Because of these risks, effective treatment or prevention is critical to ensuring cancer therapies remain on schedule and patients maintain nutrition and comfort,” reads a recent article. In response, the company is advancing a promising candidate,…

Continue Reading

FridaySep 19, 2025 10:30 am

Oncotelic Therapeutics Inc. (OTLC): Leadership and Innovation Drive Late-Stage Biotech Momentum

CEO Dr. Vuong Trieu recognized as inventor of multibillion-dollar oncology assets, including Abraxane(R) and Cynviloq(TM) OTLC advancing late-stage pipeline led by OT-101 in Phase 3 for pancreatic cancer and multiple other high-unmet-need indications Recent progress includes 2 years of steady clinical and regulatory advancements across oncology and rare pediatric programs The biotechnology sector is defined by its ability to pair scientific innovation with leadership that can translate discoveries into approved therapies. This is particularly critical in oncology, where late-stage candidates must navigate complex regulatory pathways and demonstrate real clinical impact in indications with limited treatment options. Companies that combine robust…

Continue Reading

FridaySep 19, 2025 9:50 am

QualityStocksNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Closes $375,000 Private Placement

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company developing imaging-based products for more accurate breast cancer screening, diagnosis and treatment, announced it has closed a non-brokered private placement of 1.5 million units at $0.25 per unit for gross proceeds of $375,000. Each unit includes one common share and one transferable warrant exercisable at $0.50 for three years. Proceeds will be used for general working capital. An insider acquired 100,000 units under exemptions from MI 61-101 requirements, and the company paid $3,500 and issued 14,000 broker warrants exercisable at $0.25 for three years in connection with the offering.…

Continue Reading

FridaySep 19, 2025 9:45 am

Massimo Group Inc. (NASDAQ: MAMO): How Strategic Expansion Is Redefining Distribution

Massimo's recent expansion into Oregon and Arkansas adds over 100 big-box retail locations, positioning the company for significant holiday season growth through enhanced market penetration The company's Vietnam manufacturing partnership delivers supply chain diversification and cost efficiency while maintaining quality control for its feature-rich six-seater golf carts Strategic global sourcing improvements have reduced lead times and increased operational flexibility, enabling Massimo to scale effectively during peak Q3 and Q4 demand cycles Models that relied on single-source manufacturing and regional distribution are giving way to strategies that emphasize flexibility, diversification, and rapid market penetration. BRP Inc., for example, has expanded production…

Continue Reading

FridaySep 19, 2025 9:40 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in NetworkNewsAudio Release on Innovative Therapeutics Pipeline

Oncotelic Therapeutics (OTCQB: OTLC) is featured in a new NetworkNewsAudio Audio Press Release (APR) titled “Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth.” The release highlights the leadership of chair and CEO Dr. Vuong Trieu, who has filed more than 500 patent applications and holds 75 issued patents spanning oncology, immunotherapy and nanomedicine. Dr. Trieu previously developed Abraxane(R), a nanotechnology-based formulation that transformed treatment for breast, lung and pancreatic cancers, and advanced Cynviloq(TM), a novel micellar paclitaxel therapy. The feature underscores how his track record and expertise position Oncotelic to advance pioneering therapies with strong market potential. To view…

Continue Reading

FridaySep 19, 2025 9:39 am

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Rebrands as Solmate After $300 Million PIPE Led by Pulsar Group with Backing from Solana Foundation, ARK Invest, and RockawayX

Brera Holdings (NASDAQ: BREA) will rebrand as Solmate, a Solana-focused digital asset treasury and crypto infrastructure company, following an oversubscribed $300 million private investment in public equity (PIPE). The financing was led by Pulsar Group with support from the Solana Foundation, ARK Invest and RockawayX. Marco Santori, former Chief Legal Officer of Kraken, will step in as CEO. Solmate plans to channel capital into revenue-generating infrastructure projects in the UAE, beginning with bare metal servers in Abu Dhabi built to optimize Solana validator performance. Backed by prominent blockchain and investment firms, Solmate seeks to drive Solana adoption across institutional markets,…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered